Page last updated: 2024-08-24

adapalene and Lung Neoplasms

adapalene has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chayahara, N; Doi, H; Fujishima, Y; Fukunaga, A; Kawaguchi, A; Kiyota, N; Kobayashi, K; Marugami, N; Minami, H; Mizuta, N; Mukohara, T; Nakata, K; Nishigori, C; Nishimura, Y; Tachihara, M; Takenaka, K; Tobimatsu, K; Toyoda, M; Washio, K; Yamamoto, M1
DeWitt, CA; Siroy, AE; Stone, SP1

Trials

1 trial(s) available for adapalene and Lung Neoplasms

ArticleYear
Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE).
    The oncologist, 2019, Volume: 24, Issue:7

    Topics: Acne Vulgaris; Adapalene; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Dermatologic Agents; ErbB Receptors; Exanthema; Female; Follow-Up Studies; Gels; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Protein Kinase Inhibitors

2019

Other Studies

1 other study(ies) available for adapalene and Lung Neoplasms

ArticleYear
Acneiform eruptions associated with epidermal growth factor receptor-targeted chemotherapy.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:3

    Topics: Acne Vulgaris; Adapalene; Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Colonic Neoplasms; Dermatologic Agents; Dose-Response Relationship, Drug; ErbB Receptors; Humans; Isotretinoin; Lung Neoplasms; Male; Middle Aged; Minocycline; Naphthalenes

2007